|
|
- 2016
Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndromeDOI: 10.1186/s12933-016-0473-7 Keywords: Cardiac protection, Oxidative stress, Inflammation, Metabolic syndrome, Prediabetes, Natriuresis, Adipose tissue Abstract: The potential benefit of SGLT2 inhibitors in metabolic syndrome is with prediabetic stage unclear. This work was undertaken to investigate the non-glycemic effect of empagliflozin on metabolic syndrome rats with prediabetes
|
